{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"4.0","upperLimit":"72.0","value":"29.0"}]}]}],"denomUnitsSelected":"Participants","denoms":[{"counts":[{"groupId":"OG000","value":"25"}],"units":"Participants"},{"counts":[{"groupId":"OG000","value":"38"}],"units":"MNC collections"}],"description":"Granulocyte contamination of the MNC product was quantitated as the percent of total product White Blood Cells (WBC) that were segmented granulocytes or bands.","dispersionType":"Full Range","groups":[{"description":"Multiple myeloma patients infused with autologous peripheral blood stem cells collected on the Spectra Optia Apheresis System.","id":"OG000","title":"All Per Protocol Patients"}],"paramType":"MEDIAN","populationDescription":"Data to calculate the percent of product WBCs that were segmented granulocytes or bands was available for 38 MNC collections on 25 of the 26 per protocol patients.","reportingStatus":"POSTED","timeFrame":"7 days","title":"Granulocyte % of MNC Product","type":"SECONDARY","typeUnitsAnalyzed":"MNC collections","unitOfMeasure":"percentage of product WBCs"}